The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature

ConclusionCertolizumab is efficacious in both psoriasis and PsA, including in patients who are biologic failures, and could be considered as an alternative treatment modality.

http://link.springer.com/10.1007/s13555-019-0290-5

Source: Dermatology and Therapy - March 15, 2019 Category: Dermatology Source Type: research